Homeopathic treatment of tumors of uterus

Validation of the translated Bengali version of Uterine Fibroid Symptom Quality of Life questionnaire (UFS-QOL) & open observational trial to evaluate effectiveness of individualized homoeopathic treatment of symptomatic uterine fibroids

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/013273

Enrollment

100

Registered

2018-04-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Uterine fibroid

Interventions

Intervention1: Indicated homoeopathic medicines in centesimal or fifty millesimal potencies: Indicated homoeopathic medicines in centesimal or fifty millesimal potencies, as decided appropriate to the

dosage and repetition depending upon the individual requirement of the cases. In 50 millesimal scale, a single medicated cane sugar globules of poppy seed size (no. 10) shall be dissolved in 90 ml dis

16 doses to be marked on the vial

each dose of 5 ml to be taken after 10 uniformly forceful downward strokes to the vial in 45 ml normal water in a clean cup, to stir well, to take 5 ml of this liquid orally, and to discard rest of th

Eligibility

Inclusion criteria

Inclusion criteria: 1. Premenopausal women 2. Age 18-45 years 3. Uterine fibroids confirmed by pelvic and/or transvaginal ultrasonography 4. Presence of any of the symptoms such as abnormal uterine bleeding (profuse menstruation or intercyclic menstruation), pelvic heaviness, pain during menstruation, pain during intercourse, and pressure symptoms such as urinary frequency, constipation etc. 5. Patients taking oral contraceptive pills (OCPs) will be advised to stop pills till it exhaust for the ongoing cycle, followed by re-assessment of symptoms in the next cycle enrolment 6. Patients under hormonal replacement therapy (HRT) to be included after a washout period of 3 months 7. Patients with known but controlled systemic diseases with medication 8. Ability to read Bengali 9. Patients giving written consent to participate

Exclusion criteria

Exclusion criteria: 1. Asymptomatic fibroids 2. Patients with calcified fibroid, coagulation disorders, extrauterine fibroid, polyp, cervical fibroid, any fibroid causing hydronephrosis, fibroid with solid ovarian mass 3. Unevaluated gynaecological abnormalities; e.g. unexplained vaginal bleeding, cervical dysplasia, pelvic inflammatory diseases (PID) within one month, patients with suspicious adenomyosis, gross developmental defect or congenital abnormalities of the uterus etc. 4. Patients with haemoglobin less than 7 gm/dl (severe anaemia) 5. Recent rapid growth of fibroid; i.e. doubling in size within last one to six months 6. Genito-urinary tract malignancy 7. Patients desiring immediate surgical management for uterine fibroid 8. Previous history of myomectomy, myolysis, uterine artery embolisation, etc., for uterine fibroids 9. Patients desiring for childbearing within next year 10.Patients insisting to use OCPs 11.Patients with psychiatric diseases 12.Pregnancy and lactation 13.Cases suffering from uncontrolled systemic illness or life-threatening infections or any vital organ failure 14.Cases already undergoing homoeopathic treatment for any chronic purpose 15.Substance abuse and/or dependence

Design outcomes

Primary

Measure	Time frame
Pelvic/transvaginal ultrasonographic measure of the fibroid(s)Timepoint: Baseline and 6 months	—

Secondary

Measure	Time frame
Translated Bengali version of Uterine Fibroid Symptom Quality of Life questionnaire (UFS-QOL)Timepoint: Baseline, 3 months and 6 months	—

Countries

India

Contacts

Public ContactSubhranil Saha

National Institute of Homoeopathy, Ministry of AYUSH, Govt. of India

drsubhranilsaha@hotmail.com9831063837

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026